SCHEMBL2809557

SCHEMBL2809557

N#Cc1cccc(F)c1Nc1ccc(CNC(=O)C2(C(N)=O)CC2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.38
LRRK2 Q5S007 1/20 0.37
MET P08581 1/20 0.35
ALDH1A1 P00352 1/20 0.34
CCR2 P41597 1/20 0.34
MMP8 P22894 1/20 0.33
ROCK2 O75116 1/20 0.33
NAMPT P43490 2/20 0.33
MAP3K8 P41279 1/20 0.33
AVPR2 P30518 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
MAOB P27338 1/20 0.33
RAB9A P51151 1/20 0.33
PARP1 P09874 1/20 0.32
CXCR2 P25025 1/20 0.32
MCL1 Q07820 1/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2809562 0.88 LRRK2 (0.37) METAP2LRRK2ALDH1A1CCR2ROCK2
SCHEMBL2795820 0.84 LRRK2 (0.36) METAP2LRRK2METMMP8ROCK2
SCHEMBL2810373 0.83 CYP1A2 (0.41) LRRK2ALDH1A1MAP3K8HDAC6NPC1
SCHEMBL2792629 0.80 METAP2 (0.39) METAP2LRRK2METALDH1A1NAMPT
SCHEMBL2805476 0.80 METAP2 (0.39) METAP2LRRK2METALDH1A1NAMPT
SCHEMBL2805761 0.77 BDKRB1 (0.49) LRRK2
SCHEMBL2801961 0.76 CYP2C9 (0.39) METAP2METALDH1A1NPC1POLB
SCHEMBL196872 0.75 BDKRB1 (0.40) LRRK2NAMPTMAP3K8
Trifluoroacetic Acid SCHEMBL185394 0.74 CXCR2 (0.40) LRRK2ROCK2HDAC6CXCR2JAK2
SCHEMBL2798108 0.73 TRPV1 (0.40) METAP2NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131075-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-23 US disclosed
US-20100240669-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131075-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 METAP2 3017/4885LRRK2 2304/4885MET 2161/4885
US-20100240669-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 METAP2 3017/4885LRRK2 2304/4885MET 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.